Astrocytes: Master Regulators of the Brain

For more than a century after their initial identification, astrocytes were largely relegated to the background of neurobiology, dismissed as passive cellular glue that merely insulated and structurally anchored the electrical machinery of neurons. Contemporary neuroscience has thoroughly overturned this neurocentric dogma, revealing that astrocytes are highly active, chemically dynamic computational elements indispensable for brain development, synaptic transmission, metabolic homeostasis, and neurological disease. Far from functioning as silent onlookers, these complex glial cells coordinate neural communication and protect central nervous system architecture across the human lifespan.

Astrocyte

1. Concise Definition

An astrocyte is a specialized, star-shaped non-neuronal glial cell residing within the central nervous system (CNS) that fulfills critical structural, metabolic, regulatory, and signaling functions. Along with oligodendrocytes, ependymal cells, and microglia, astrocytes constitute the neuroglia of the brain and spinal cord, representing one of the most abundant and morphologically intricate cellular populations in the mammalian nervous system.

Functionally, an astrocyte acts as a homeostatic architect and active signaling partner. Each individual astrocyte extends thousands of delicate, highly branched cytoplasmic processes that envelop neuronal somas, dendrites, and tens of thousands of individual synapses, while simultaneously casting expanded cellular projections—termed perivascular endfeet—onto cerebral microvessels. Through this strategic anatomical bridging between the vascular supply and synaptic circuitry, astrocytes govern the formation and integrity of the blood-brain barrier, buffer extracellular ions, recycle neurotransmitters, supply metabolic substrates to active neurons, and actively modulate synaptic efficacy through calcium-mediated chemical signaling.

2. Etymology & Linguistic Origin

The term astrocyte is derived directly from classical Greek linguistic roots. It combines the Ancient Greek word astron (ἄστρον), meaning “star” or “celestial body,” with kytos (κύτος), signifying a “hollow vessel,” “container,” or modernly, a biological “cell.” The literal etymological translation is therefore “star-shaped cell,” describing the radiant, stellate arborization observed under early light microscopy.

The specific designation was formally introduced into anatomical literature in 1893 by the Hungarian anatomist and histologist Michael von Lenhossék. Working during the nascent era of the “Neuron Doctrine,” Lenhossék sought to distinguish these star-like supporting cells from neighboring neuronal elements and other non-neuronal entities within the gray and white matter of the neuroaxis.

3. Pronunciation & Grammatical Form

The standard pronunciation of astrocyte in International Phonetic Alphabet (IPA) notation is:

• Received Pronunciation (British English): /ˈæs.trə.saɪt/
• General American English: /ˈæs.troʊˌsaɪt/

Grammatically, the word is a countable noun. Its plural form is astrocytes. The term gives rise to several essential derived forms frequently utilized across neuroscientific literature, including the descriptive adjective astrocytic (e.g., “astrocytic endfeet,” “astrocytic domain”), the collective abstract noun astroglia (referring broadly to the lineage or total population of astrocytic cells), and the pathological noun astrogliosis (denoting the structural and phenotypic transformation of astrocytes in response to CNS trauma or disease).

4. Detailed Conceptual Explanation

To conceptualize the astrocyte is to appreciate an extraordinary triumph of biological compartmentalization and spatial optimization. Unlike neurons, which transmit action potentials over extended axonal distances via classical electrical impulses, astrocytes are electrically non-excitable in the traditional sense; they do not fire standard voltage-gated action potentials. Instead, astrocytes operate using an intricate, chemical form of excitability governed predominantly by intracellular calcium (Ca²⁺) oscillations and widespread gap-junction coupling.

A hallmark feature of mature protoplasmic astrocytes in the cerebral cortex and hippocampus is their strict spatial tiling or domain organization. Each astrocyte occupies a discrete, non-overlapping anatomical territory. Within its three-dimensional microdomain, a single rodent astrocyte can interact with upwards of 100,000 synapses, whereas an extensively branched human neocortical astrocyte may contact and modulate up to two million synapses simultaneously. The peripheries of neighboring astrocytic territories exhibit minimal interdigitation, ensuring that individual astrocytes exert autonomous physiological jurisdiction over dedicated clusters of neuronal synapses and capillary segments.

At the capillary interface, specialized astrocytic endfeet virtually encase the cerebral vasculature, forming the perivascular glia limitans. These endfeet express exceptionally high concentrations of the water channel protein Aquaporin-4 (AQP4). This molecular architecture permits astrocytes to regulate local cerebral blood flow in response to regional synaptic activity—a physiological coupling known as neurovascular coupling or functional hyperemia. Furthermore, polarized AQP4 channels drive the convective bulk flow of interstitial fluid through the brain parenchyma, facilitating metabolic waste clearance via the glymphatic system during slow-wave sleep.

At the synaptic interface, astrocytic processes form an intimate physical association with both the presynaptic axon terminal and the postsynaptic dendritic spine. This anatomical arrangement underpins the revolutionary paradigm known as the tripartite synapse. In this framework, astrocytes do not simply observe neurotransmission; they directly participate in it. When neurons release neurotransmitters such as glutamate into the synaptic cleft, astrocytic high-affinity glutamate transporters (primarily GLT-1/EAAT2 and GLAST/EAAT1) rapidly clear glutamate from the extracellular space, preventing neurotoxic overactivation of postsynaptic receptors. Astrocytes convert this internalized glutamate into harmless glutamine via the astrocyte-specific enzyme glutamine synthetase, subsequently exporting glutamine back to neurons to replenish presynaptic neurotransmitter pools—a homeostatic metabolic loop designated the glutamate-glutamine cycle.

5. Historical Development

The scientific trajectory of astrocyte research spans nearly two centuries, characterized by consecutive phases of anatomical discovery, physiological dismissal, and eventual functional revolution:

In 1858, the German pathologist Rudolf Virchow introduced the concept of Nervenkitt (neuroglia or “nerve-glue”), postulating that the interstitial space between cerebral neurons was occupied by an amorphous, non-cellular connective substance whose sole purpose was to hold neuronal circuits together. Decades later, the development of metallic histological staining techniques permitted finer microscopic resolution. In the 1870s and 1880s, Camillo Golgi employed his revolutionary silver nitrate impregnation (the “black reaction”), visualizing for the first time distinct, spider-like cellular bodies within the neuroglia that extended processes to nearby blood vessels.

The definitive early morphological characterization of astrocytes was achieved by the Spanish neuroanatomist Santiago Ramón y Cajal in the early twentieth century. Cajal developed the gold sublimate staining method, which specifically labeled the intermediate filaments of astrocytes. Cajal meticulously documented their extensive structural heterogeneity, classifying them into protoplasmic and fibrous varieties, and presciently hypothesized that astrocytes might dynamically insulate synapses or modulate physiological sleep cycles.

Despite Cajal’s visionary insights, mid-twentieth-century neuroscience remained predominantly electrophysiological, focusing on action potentials, oscilloscope traces, and axonal conducting paths. Because microelectrodes inserted into astrocytes recorded stable negative resting membrane potentials devoid of action potentials, these cells were long designated “electrically silent” and neglected. The conceptual renaissance began in the late 1980s and 1990s with the advent of fluorescent calcium indicator dyes, two-photon laser scanning microscopy, and molecular genetics. Pioneering research demonstrated that astrocytes respond to neurotransmitters with complex, propagating intracellular calcium waves, enabling them to communicate with each other via gap junctions and release their own neuroactive signaling molecules, fundamentally redefining their standing in modern neurobiology.

6. Theoretical Foundations

Modern astroglial biology is grounded upon several interlocking theoretical frameworks that describe how non-excitable cells coordinate higher-order nervous system operations:

The Tripartite Synapse Hypothesis: Formulated systematically in the late 1990s by Alfonso Araque, Vladimir Parpura, Philip G. Haydon, and colleagues, the tripartite synapse model asserts that conventional synaptic transmission cannot be understood solely as a dialogue between a presynaptic terminal and a postsynaptic density. Instead, the perisynaptic astrocytic process represents an obligatory third element. Under this paradigm, astrocytes sense spillover neurotransmitters through high-affinity metabotropic receptors, generate intracellular IP₃-dependent calcium transients, and subsequently release chemical messengers—termed “gliotransmitters” (including D-serine, adenosine triphosphate [ATP], and glutamate)—that bind presynaptic and postsynaptic receptors to modulate synaptic strength and long-term plasticity.

The Astrocyte-Neuron Lactate Shuttle (ANLS): Proposed in 1994 by Luc Pellerin and Pierre Magistretti, this bioenergetic theory resolves the longstanding question of how the brain fuels intense, focal computational activity. The ANLS posits that synaptic release of glutamate triggers sodium-dependent glutamate uptake into astrocytes. This stimulates astrocytic aerobic glycolysis, converting blood-borne glucose or intracellular glycogen stores into lactate. The astrocyte then extrudes lactate via monocarboxylate transporters (MCT1 and MCT4) into the extracellular space, where adjacent neurons absorb it via MCT2 to feed directly into the tricarboxylic acid (TCA) cycle for oxidative ATP production.

Spatial Potassium (K⁺) Buffering: Originating from the theoretical work of Richard Kuffler and colleagues in the 1960s, this biophysical model explains how the CNS maintains ionic stability. During prolonged neuronal firing, extracellular potassium concentrations rise dramatically, which would dangerously depolarize nearby axons if left unchecked. Astrocytes maintain an exceptionally negative resting membrane potential (around -80 to -90 mV) driven by inwardly rectifying potassium channels (primarily Kir4.1). Astrocytes take up excess local extracellular K⁺ and redistribute it across extensive syncytial networks linked by connexin gap junctions (Cx43 and Cx30), dissipating the ionic load safely into distant regions or perivascular sinks.

7. Key Components, Types & Dimensions

Astrocytes exhibit profound regional, morphological, and functional diversity across the mammalian neuroaxis. The primary identified subtypes and anatomical dimensions include:

• Protoplasmic Astrocytes: Located primarily throughout the cerebral gray matter. These cells exhibit a globoid morphology characterized by countless finely branched, bush-like processes that envelop neuronal somas, synapses, and local microvessels within tightly bounded, non-overlapping spatial domains.
• Fibrous Astrocytes: Situated within the myelinated white matter tracts (e.g., corpus callosum, optic nerve). Morphologically, they possess elongated, smooth, relatively unbranched processes oriented parallel to nerve fibers, where their specialized endfeet frequently contact the nodes of Ranvier to stabilize axonal conduction.
• Bergmann Glia: Specialized unipolar radial astrocytes of the cerebellar cortex. Their cell bodies reside within the Purkinje cell layer, extending straight, palisading vertical processes through the molecular layer to the pial surface. They play an irreplaceable role in guiding granule cell migration during development and modulating Purkinje cell synapses.
• Müller Glia: The principal radial glial cells of the vertebrate retina. Spanning the entire thickness of the retinal neural layer, they maintain structural integrity, modulate photoreceptor function, buffer ions, and process visual information.
• Interlaminar Astrocytes: Primate- and human-specific astrocytes located in cortical Layer I. They feature compact cell bodies that cast remarkably long, unbranched, tortuous processes downward through layers II, III, and IV, establishing structural and computational columns unique to advanced mammalian brains.
• Reactive Astrocytes: A spectrum of functionally altered astrocytes induced in response to CNS trauma, stroke, or neurodegeneration. Rather than existing as a uniform population, reactive astrocytes adopt diverse phenotypes ranging from neuroprotective and scar-forming cells that restrict damage to neuroinflammatory, dysfunctional phenotypes that exacerbate neurotoxicity.

8. Examples & Illustrative Cases

To observe astrocytic function in concrete neurobiological scenarios, consider the following real-world physiological and pathological contexts:

Case 1: Developmental Synaptic Pruning: During early postnatal brain development, the central nervous system produces an overabundance of synaptic connections. Astrocytes actively sculpt neural circuits by selecting and eliminating redundant synapses. Seminal research spearheaded by Ben Barres and colleagues revealed that astrocytes secrete transforming growth factor-beta (TGF-β), which instructs neurons to upregulate complement cascade component C1q onto weak synapses. Astrocytic phagocytic receptors, specifically MEGF10 and MERTK, then directly recognize, engulf, and degrade these tagged synaptic elements, ensuring proper circuit refinement and preventing neurodevelopmental disorders.

Case 2: Focal Ischemic Stroke and Glial Scarring: In the event of a middle cerebral artery occlusion, the resulting cerebral ischemia causes widespread neuronal death and uncontrolled glutamate release. Perilesional astrocytes undergo dramatic hypertrophy and molecular remodeling, upregulating intermediate filaments such as Glial Fibrillary Acidic Protein (GFAP) and vimentin. These reactive astrocytes migrate to the perimeter of the necrotic core, interweaving their hypertrophic processes to form a dense biological barricade known as the glial scar. While this scar historically was viewed as an impediment to axonal regeneration, contemporary work proves it is an essential defense that sequesters toxic inflammatory debris, prevents microbial invasion, and protects surviving adjacent parenchyma.

Case 3: Alexander Disease: Alexander disease is a rare, devastating human leukodystrophy characterized pathologically by the presence of Rosenthal fibers (protein aggregates) within the cytoplasm of astrocytes. Unlike most neurodegenerative conditions driven by neuronal mutations, Alexander disease is directly caused by heterozygous, dominant gain-of-function mutations in the GFAP gene encoding the astrocytic intermediate filament. The accumulation of mutant GFAP overwhelms the astrocytic proteasome, triggering cellular stress, loss of glutamate clearance, demyelination, and fatal seizure disorders—illustrating that primary astrocytic failure is sufficient to drive widespread nervous system destruction.

9. Measurement & Assessment

Investigating astrocytes requires specialized molecular, physiological, and imaging methodologies capable of parsing their non-electrical activity and nanoscale morphology:

Immunohistochemical and Molecular Biomarkers: Astrocytes are typically identified and quantified in tissue sections using specific molecular targets:

• GFAP (Glial Fibrillary Acidic Protein): The classical intermediate filament marker; highly abundant in fibrous astrocytes and reactive states, though expressed at lower levels in resting protoplasmic astrocytes of the cortex.
• ALDH1L1 (Aldehyde Dehydrogenase 1 Family Member L1): Recognized as a broader and more pan-astrocytic marker that labels both soma and fine processes irrespective of reactive state.
• S100B: A soluble calcium-binding protein expressed prominently by astrocytes, widely utilized both in histological staining and as a serum biomarker of traumatic brain injury and blood-brain barrier disruption.
• EAAT2 / GLT-1: High-affinity glutamate transporters enriched on astrocytic perisynaptic membranes, quantified via Western blotting or immunohistochemistry to assess synaptic clearance capacity.

Two-Photon Laser Scanning Microscopy & Genetically Encoded Indicators: Because astrocytes do not produce voltage spikes, their physiological dynamics are monitored via intracellular Ca²⁺ fluctuations. Researchers utilize genetically encoded calcium indicators (such as GCaMP6 and GCaMP7) targeted selectively to astrocytes under specific promoters (e.g., GfaABC1D). Coupled with in vivo two-photon microscopy, this technology permits the visualization of microdomain calcium transients in awake, behaving animals in response to sensory stimulation or behavioral tasks.

Single-Cell and Spatial Transcriptomics: Contemporary investigations utilize single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics to dissect the profound heterogeneity of astrocytes across distinct brain regions. These methods have demonstrated that astrocytes exhibit specialized molecular signatures tailored to the specific neuronal subtypes they envelop, disproving the notion of a homogenous, generic glial population.

10. Applications & Practical Significance

The translation of basic astrocytic research into clinical neurology, psychiatry, and pharmacology represents one of the fastest-growing frontiers in biomedicine:

Therapeutics for Neurodegenerative Diseases: In conditions such as Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s disease, and Huntington’s disease, astrocytes lose their neuroprotective capacity and adopt cytotoxic behaviors. In ALS, astrocytes harboring SOD1 mutations downregulate the EAAT2 transporter, resulting in excitotoxic motor neuron death. Pharmaceutical efforts focus on developing small-molecule enhancers of astrocytic glutamate uptake (e.g., ceftriaxone derivatives or novel transcriptomic modulators) to shield motor neurons from excitotoxicity.

Targeting the Glymphatic System: The discovery that astrocytic AQP4 water channels mediate sleep-dependent clearance of neurotoxic proteins—including amyloid-beta and hyperphosphorylated tau—has revolutionized therapeutic approaches to dementia. Optimizing sleep architecture, pharmacologically stabilizing AQP4 polarization at the perivascular endfoot, or enhancing interstitial convective flow are emerging as viable disease-modifying strategies for Alzheimer’s disease and related tauopathies.

Psychiatric Medicine: Post-mortem studies of patients diagnosed with Major Depressive Disorder (MDD) consistently reveal marked reductions in astrocytic density and down-regulation of glial markers in the prefrontal cortex and amygdala. The rapid-acting antidepressant ketamine has been shown to restore astrocytic networks and stimulate the astrocytic release of brain-derived neurotrophic factor (BDNF) and ATP, establishing astrocytes as vital cellular targets for novel psychiatric drug discovery.

11. Research & Empirical Evidence

Decades of rigorous laboratory experiments and clinical investigations have solidified the active role of astrocytes across multiple domains of brain function:

The bioenergetic significance of astrocytes was empirically verified in seminal studies by Pellerin and Magistretti (1994, PNAS), demonstrating that glutamate uptake into cultured astrocytes stimulated a dose-dependent increase in glucose utilization and lactate extrusion, laying the biochemical foundation for the ANLS. Subsequent in vivo carbon-13 magnetic resonance spectroscopy (¹³C-MRS) experiments in human patients confirmed that substantial cerebral energy flow passes through the astrocytic glycolytic pathway before utilization by neuronal mitochondria.

In a milestone study regarding synaptic connectivity, Christopherson et al. (2005, Cell) from the laboratory of the late Ben Barres established that purified retinal ganglion neurons cultured in the complete absence of astrocytes formed minimal, functionally immature synapses. Addition of astrocyte-conditioned medium or purified astrocytic proteins, specifically thrombospondins (TSP-1 and TSP-2), induced a dramatic, multifold increase in the structural formation of active synapses, demonstrating that synaptogenesis is fundamentally orchestrated by astroglial signaling.

The role of astrocytes in systemic glymphatic clearance was established by Lulu Xie, Maiken Nedergaard, and colleagues (2013, Science). Utilizing real-time two-photon imaging in mice, Nedergaard’s group demonstrated that the interstitial space volume fraction expands by over 60% during natural sleep or anesthesia, driven by astrocytic AQP4 channels. This expansion facilitated a dramatic increase in the convective clearance of radiolabeled amyloid-beta compared to the waking state, providing the first definitive biological explanation for why all mammalian life requires restorative sleep.

12. Cultural & Cross-Cultural Considerations

While cellular biology is fundamentally universal across human populations, significant evolutionary and comparative neurobiological distinctions characterize the human astrocyte when contrasted with other species:

Evolutionarily, human astrocytes have diverged drastically from their non-primate counterparts. A single human protoplasmic astrocyte is roughly twenty-seven times larger in volume than a rodent astrocyte, extends ten times more primary processes, and envelops up to twenty times more synapses. Furthermore, hominid brains possess unique astrocytic classes, including the aforementioned interlaminar astrocytes in superficial cortical layers and giant varicose projection astrocytes in deep layers, which are completely absent in rodents.

To assess the cognitive significance of these human-specific evolutionary adaptations, Han et al. (2013, Cell Stem Cell) engrafted human glial progenitor cells into the brains of neonatal immune-deficient mice. The transplanted human astrocytes matured, retained their massive size and complex arborization, and successfully integrated into the host rodent neural circuits. Remarkably, the chimeric mice harboring human astrocytes exhibited dramatically enhanced long-term potentiation (LTP) in the hippocampus and navigated spatial memory tasks, such as the Barnes maze and fear conditioning paradigms, significantly faster than unengrafted littermates. These profound empirical findings indicate that the evolutionary specialization of human astroglia contributed directly to the expansion of human cognitive capacity.

13. Criticisms, Debates & Limitations

Despite remarkable breakthroughs, the field of astroglial biology has been marked by fierce scientific controversies, competing interpretations, and methodological hurdles:

The Gliotransmission Controversy: The most contentious debate in glial biology centers on whether physiological astrocytes release chemical neurotransmitters via vesicular, calcium-dependent exocytosis under normal in vivo conditions. Critics, notably Ken McCarthy and colleagues, engineered transgenic mouse models (such as the IP3R2 knockout mouse) in which astrocytic calcium signaling was genetically eliminated. Surprisingly, these mice exhibited normal basal synaptic transmission, normal long-term potentiation, and unimpaired behavioral performance in multiple standard paradigms, prompting skeptics to argue that “gliotransmission” may be an artifact of non-physiological pharmacological stimulation or cultured cell preparations. Proponents counter that alternative calcium sources (such as mitochondrial exchange or membrane channels like TRPA1) compensate in knockout animals, leaving the precise physiological scope of vesicular gliotransmission an active, unresolved question.

The Binary A1/A2 Dichotomy Oversimplification: In 2017, an influential paradigm categorized reactive astrocytes into two binary phenotypes: neurotoxic “A1” astrocytes (induced by activated microglia secreting IL-1α, TNF-α, and C1q) that kill neurons and oligodendrocytes, and neuroprotective “A2” astrocytes (induced by ischemia) that promote tissue repair. However, in 2021, an international consortium of leading glial biologists published a consensus statement in Nature Neuroscience urging the field to abandon this simplistic binary nomenclature. Transcriptomic analyses revealed that reactive astrocytes exist along a continuous, multidimensional spectrum influenced by regional context, local microenvironments, sex, and specific disease states, rendering the A1/A2 binary construct an oversimplified model.

14. Related Terms & Distinctions

To prevent conceptual confusion, astrocytes must be distinguished from other neural and non-neuronal cells within the central nervous system:

• Astrocytes vs. Oligodendrocytes: Both are macroglial cells derived from neuroectoderm. However, while astrocytes manage metabolic balance, blood-brain barrier maintenance, and synaptic regulation, oligodendrocytes specialize exclusively in synthesizing myelin sheaths that wrap CNS axons to facilitate saltatory nerve impulse conduction.
• Astrocytes vs. Microglia: Astrocytes originate from neuroepithelial progenitor cells, whereas microglia originate from mesodermal primitive myeloid progenitors in the embryonic yolk sac. Microglia represent the brain’s resident macrophage immune system, responsible for inflammatory monitoring, phagocytosis of pathogens, and innate immune surveillance.
• Astrocytes vs. Neurons: Neurons are electrically excitable cells characterized by polarized axons and dendrites that propagate all-or-none action potentials. Astrocytes are non-spiking cells lacking typical axons, utilizing intracellular calcium waves and gap junction syncytia to perform supportive, computational, and homeostatic roles.
• Astrocytes vs. Ependymal Cells: Ependymal cells form a simple ciliated epithelial monolayer lining the cerebral ventricular system and central canal of the spinal cord, responsible for circulating cerebrospinal fluid (CSF), whereas astrocytes populate the parenchyma and establish the glia limitans.

15. Summary / Key Takeaways

Astrocytes have evolved from their historic status as passive anatomical connective tissue into recognized, indispensable masters of brain physiology. Positioned uniquely between cerebral microvessels and neuronal synapses, they execute an astonishing array of critical responsibilities: they establish and maintain the blood-brain barrier, regulate local blood flow via neurovascular coupling, fuel neurons via lactate shuttling, rapidly clear neurotransmitters to prevent excitotoxicity, sculpt developmental circuits through synaptic pruning, and facilitate restorative metabolic waste clearance through the glymphatic system.

Understanding the dynamic molecular, structural, and physiological complexity of astrocytes continues to revolutionize modern neuroscience. As clinical research shifts beyond exclusively targeting neuronal pathology, modulating astrocytic reactivity, restoring glial homeostatic mechanisms, and leveraging human-specific astroglial capabilities are emerging as premier frontiers for treating neurological, neurodegenerative, and psychiatric disorders.

References

• Araque, A., Sanzgiri, R. P., Parpura, V., & Haydon, P. G. (1999). Astrocyte-neuron signaling: The tripartite synapse. Trends in Neurosciences, 22(5), 208–215. https://doi.org/10.1016/S0166-2236(98)01349-6
• Christopherson, K. S., Ullian, E. M., Stokes, C. C., Mullowney, C. E., McConnell, J. W., El-Sabeawy, N., Brown, S., & Barres, B. A. (2005). Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell, 120(3), 421–433. https://doi.org/10.1016/j.cell.2004.12.020
• Escartin, C., Galea, E., Lakatos, A., O’Callaghan, J. P., Petzold, G. C., Serrano-Pozo, A., Steinhäuser, C., Volterra, A., Carmignoto, G., Pekny, M., Verkhratsky, A., & Sofroniew, M. V. (2021). Reactive astrocyte nomenclature, definitions, and future directions. Nature Neuroscience, 24(3), 312–325. https://doi.org/10.1038/s41593-020-00783-4
• Han, X., Chen, M., Wang, F., Windrem, M., Wang, S., Shanz, S., Xu, Q., Oberheim, N. A., Bekar, L., Betstadt, S., Silva, A. J., Takano, T., Goldman, S. A., & Nedergaard, M. (2013). Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell, 12(3), 342–353. https://doi.org/10.1016/j.stem.2012.12.015
• Pellerin, L., & Magistretti, P. J. (1994). Glutamate uptake into astrocytes stimulates aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization. Proceedings of the National Academy of Sciences, 91(22), 10625–10629. https://doi.org/10.1073/pnas.91.22.10625
• Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., Takano, T., Deane, R., & Nedergaard, M. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342(6156), 373–377. https://doi.org/10.1126/science.1241224